MapLight Therapeutics (MPLT) Cash from Investing Activities (2024 - 2025)
MapLight Therapeutics (MPLT) reported Cash from Investing Activities of -$242.6 million for Q4 2025, down 848.76% on a YoY basis from $32.4 million in Q4 2024, and down 848.76% sequentially from $32.4 million in Q4 2024.
MapLight Therapeutics (MPLT) Cash from Investing Activities (2024 - 2025) Analysis & Trends
MapLight Therapeutics (MPLT) has 2 years of Cash from Investing Activities data on file, last reported at -$242.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.62 Bn | 466.83 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | -25.54 Mn |
| 10 | MapLight Therapeutics | 96.62 Mn | 96.62 Mn | - | -242.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -242.55 Mn |
| Dec 31, 2025 | -242.55 Mn |
| Dec 31, 2024 | 32.39 Mn |
| Dec 31, 2024 | 32.39 Mn |